Is the information "fair and balanced" in direct-to-consumer prescription drug websites?

Jisu Huh, Brenda J. Cude

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Abstract

This study applies the Food and Drug Administration's (FDA's) "fair-balance disclosure" provision to examine the content of prescription drug websites, specifically focusing on the quantity and quality of risk information. The results show that even though most prescription drug websites provide both risk and benefit information, the two types of information are presented differently. This study suggests directions for regulators to consider in writing a more specific rule to ensure that information on prescription drug websites is balanced.

Original languageEnglish (US)
Pages (from-to)529-540
Number of pages12
JournalJournal of Health Communication
Volume9
Issue number6
DOIs
StatePublished - Nov 2004

Bibliographical note

Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Is the information "fair and balanced" in direct-to-consumer prescription drug websites?'. Together they form a unique fingerprint.

Cite this